FDA Inspection
Hospira, Inc.Hospira, Inc. – FDA Inspection, Nov 14, 2023
Record Details
This FDA Inspection record concerns Hospira, Inc., with an inspection on November 14, 2023, issued by the Atlanta District Office.
- Company
- Hospira, Inc.
- Inspection Date
- November 14, 2023
View Company Profile
ID · f035aae9-e0b2-49a1-a514-e54edbf04704
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1223090
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hospira, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2025 | Not classified | Atlanta District Office | |
| November 21, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 2, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 26, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 24, 2015 | VAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for Hospira, Inc.
- FDA Inspection 1251941 - 2025-02-07
- FDA Inspection 1110899 - 2019-11-21
- FDA Inspection 1039547 - 2018-02-02
- FDA Inspection 984874 - 2016-05-26
- FDA Inspection 942202 - 2015-09-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.